Venus Remedies awarded GMP certification by Libya, Health News, ET HealthWorld

[ad_1]

New Delhi: Venus Remedies has been awarded the good manufacturing practices (GMP) certification for its facilities from the Ministry of Health, Libya.

Libya’s pharmaceutical imports, valued at $514 million in 2021, have grown at a rate of 2.81 per cent over the previous year. Its strategic location in Africa and evolving pharmaceutical landscape provide Venus Remedies with an opportunity to contribute positively to the region’s healthcare sector. The $46.8 billion pharmaceutical market of Africa, as of 2022, is expected to grow at a CAGR of 8.3 per cent to reach $110.9 billion by 2023. This certification is a step towards enhancing the company’s presence in Africa.

Saransh Chaudhary, CEO, Venus Medicine Research Centre, said, “The GMP certification from Libya adds to Venus Remedies’ portfolio of international approvals from 25 regulators, complementing our existing certifications in Africa from Morocco, South Africa, Tanzania, Kenya, Uganda, Sudan, and other African countries. This GMP certification reflects our collaborative efforts in the African pharmaceutical industry, a key focus area of our global expansion strategy.”

Akshansh Chaudhary, Executive Director, Venus Remedies, said, “We are thankful to our customers, partners, and stakeholders for their constant support. Their trust in our company drives our pursuit of excellence.”

  • Published On Jan 24, 2024 at 03:46 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *